B
LOXO

BP’s Loxo Oncology, Inc LOXO Stock Holding History

BP’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-7,624
Closed -$245K – 451
2016
Q4 		$245K Buy
+7,624
New +$195K 0.01% 429

Other funds holding LOXO

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BP's LOXO Position: Q1 2017 in Review

BP sold out of Loxo Oncology, Inc (LOXO) in Q1 2017, closing a stake of 7,624 shares — an estimated $245K sold.

BP first reported a position in LOXO in Q4 2016 and held it in 1 quarter. The position peaked at $245K in Q4 2016. 86 funds tracked by Wall St. Rank hold LOXO as of Q1 2017.

  • BP reported no remaining Loxo Oncology, Inc position as of Q1 2017 after selling out during the quarter.
  • BP sold 7,624 Loxo Oncology, Inc shares in Q1 2017, an estimated $245K.
  • BP first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 1 quarter.
  • BP's Loxo Oncology, Inc position peaked at $245K in Q4 2016.
  • 86 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2017.

Based on BP's 13F filing for Q1 2017, filed 9 May 2017.